Summary In squamous cell carcinoma of the head and neck (SCCHN), DNA ploidy as determined by flow cytometry (FCM) has been found to yield prognostic information but only for tumours at oral sites. Cytogenetic findings have indicated complex karyotype to be a correlate of poor clinical outcome. In the present study, 73 SCCHN were investigated with the two techniques. Aneuploid cell populations were identified in 49 (67%) cases by FCM but in only 21 (29%) cases by cytogenetic analysis. The chromosome index (Cl), calculated as the mean chromosome number divided by 46, was compared with the respective DNA index (Dl) obtained by FCM in 15 tumours, non-diploid according to both techniques, Dl being systematically 12% higher than Cl in this subgroup. Eight (33%) of the 24 tumours diploid according to FCM had complex karyotypes, three of the tumours being cytogenetically hypodiploid, three diploid and two non-diploid. The findings in the present study may partly explain the low prognostic value of ploidy status as assessed by FCM that has been observed in SCCHN. In addition, we conclude that FCM yields information of the genetic changes that is too unspecific, and that cytogenetic analysis shows a high rate of unsuccessful investigations, thus diminishing the value of the two methods as prognostic factors in SCCHN.
DNA ploidy determined by flow cytometry (FCM) is an established prognostic variable in patients with various solid tumours, e.g. breast cancer (Clark et al, 1989) , in whom it has an impact on treatment strategy. For squamous cell carcinoma of the head and neck (SCCHN), the results have not been unequivocally conclusive for tumours at sites other than the oral cavity, a category in which patients with DNA diploid tumours are characterized by a better survival rate than those with aneuploid tumours (Stell, 1991) . However, ploidy status as assessed by FCM might enable response to a given therapy to be predicted, as non-diploid tumours have been reported to be more sensitive than diploid tumours to chemotherapy (Ensley et al, 1990; Tennvall et al, 1993) . The method is fast, with a high rate of successful analysis, and is thus appropriate for daily clinical work. However, it is a crude way of determining genetic alterations; for example small non-diploid clones can be difficult to detect and pseudodiploid/near-diploid tumours may yield false normal results. In some tumour types (e.g. soft tissue sarcoma), attempts have been made to improve the subclassification by assessing breadth and skewness of the DNA diploid G/G, peak Gustafson, 1994) .
Chromosomal abnormalities determined by cytogenetic analysis are established prognostic factors in patients with haematological malignancies, in particular childhood acute lymphoblastic leukaemia (Pui and Crist, 1992) . Because of technical difficulties in establishing short-term cultures, cytogenetic information from solid tumours is more limited. However, data are now accumulating; for SCCHN, complex karyotypes, in general, and rearrangements of band 1 1q 13, in particular, have been found to be associated with poor prognosis Correspondence to: J Akervall banding analysis is time-consuming, but provides detailed and reliable information about the genetic changes that have occurred. The frequency of non-diploid tumours is lower as determined by cytogenetic analysis (Jin et al, 1993 than as determined by FCM (Stell, 1991) , which may reflect difficulties in culturing certain non-diploid cell populations. Problems with poor growth of tumour cells, overgrowth of stromal cells and suboptimal chromosome preparations clearly diminish the success rate.
Earlier comparisons of FCM and cytogenetic analysis in various solid tumours, i.e. colorectal tumours, renal cell carcinoma and malignant mesothelioma, have usually shown good correspondence between DNA index and chromosome number (Petersen and Friedrich, 1986; Remvikos et al, 1988a; Ljungberg et al, 1991; Pyrhonen et al, 1992) , although some discrepancies have also been noted (Smeets et al, 1987; Remvikos et al, 1988b; Wolman et al, 1988; El-Naggar and Pathak, 1992) . Furthermore, it has been shown that a large proportion of flow cytometrically diploid tumours have karyotype abnormalities when analysed cytogenetically (Cabanillas et al, 1986; Smeets et al, 1987; Breitkreutz et al, 1993; Laquerriere et al, 1993; Mandahl et al, 1993; Matsuyama et al, 1994) .
Hitherto, there have been no reports of a comparison of data elicited with the two methods in SCCHN. The aim of the present study was to compare DNA FCM and cytogenetics in SCCHN and to assess the applicability of the methods in clinical work.
MATERIALS AND METHODS Tumour sampling
Tumour samples were obtained from diagnostic biopsies or at surgery from October 1990 to the end of February 1994. All samples were divided into three parts: one for histopathological examination, one for storage at -70°C in dimethyl sulphoxide citrate buffer (DMSO) before FCM and one for cytogenetic analysis.
Tumour characteristics One hundred and four samples from patients with SCCHN were analysed with FCM and cytogenetic banding techniques. Of these, 31 yielded no karyotype information because of either infection or poor growth in cell culture. Thus, a total of 73 samples were successfully analysed with both techniques. All but two of the patients had primary, untreated tumours.
Five sites were represented: oral cavity in 27 cases, oropharynx in 14, hypopharynx in seven, larynx in 19, skin in three and nasal cavity, lymph node of unknown origin and oesophagus in one case each. Of the 67 patients with tumours at one of the first four sites, 31 (46%) manifested lymph node metastasis at diagnosis. The TNM distribution is shown in Table 1 . The tumours were classified according to the International Union Against Cancer criteria (Hermanek et al, 1987) .
Cytogenetic analysis
The samples were processed as described earlier (Jin et al, 1993) . In brief, the fresh tumour samples were minced, disaggregated overnight in collagenase and plated onto collagen-coated chamber slides in a chemically defined, serum-free medium. The in situ preparations were harvested after 5-10 days. G-banding was obtained with Wright's stain. Clonality criteria and chromosome abnormalities were defined according to the International System for Human Cytogenetic Nomenclature (ISCN, 1991) .
The karyotypes were divided into four groups: normal karyotype, numerical changes only, simple structural changes (one to three changes) or complex structural changes (more than three changes).
Chromosome index (CI) was defined as the quotient of the mean chromosome number divided by 46.
FCM
The FCM procedure used (Wennerberg et al, 1996) was a modification of that previously described (Tribukait et al, 1975; Vindelov, 1977) . In brief, the tumour samples were processed by a combined mechanical, enzymatic and detergent procedure to obtain nuclear suspension. The nuclear DNA was incubated in a solution containing 50 ig ml-' propidium iodide (PI) and 0.6% detergent (Nonidet P40) dissolved in Tris buffer. Analysis was performed in a Cytofluorograph System 50-H (Ortho Instruments, Westwood, MA, USA). Approximately 10 000-20 000 nuclei were analysed in each sample. Cell doublets were excluded by electronic threshold settings (Baldetorp et al, 1989) .
Ploidy status was classified on DNA histograms as follows: one single GO/GI peak, diploid; two or more peaks, non-diploid (Hiddemann et al, 1984) . The DNA Index (DI) for the non-diplod stemline was calculated as the ratio between its GO/GI peak position and the diploid peak position in the same histogram. DI for the diploid stemline was defined as 1.00. Histograms with at least three stemlines were classified as multiploid. The S-phase fraction (Spf) was calculated using a planimetric method, assuming the fluorescence intensity values between GJG, and G2 peaks to represent DNA-synthesizing cells that are rectangularly distributed (Baisch et al, 1975) .
In all cases, the width of the GJ1G, peak was determined in terms of the coefficient of variation (CV) calculated at the base of the diploid GJG, peak in the DNA histogram, and asymmetry of the GO/GI peak was determined in terms of skewness assessed independently by two observers (JA and BB). Both of these variables are considered to reflect the presence of small near-diploid cell populations 
RESULTS
The distribution of karyotypes, CI, DI, CV and Spf is shown in Table 1 . Of the 73 tumours in the series as a whole, 52 (71 %) were diploid according to cytogenetic analysis and 24 (33%) diploid according to FCM. Of the latter subgroup, 33% (8 out of 24) had a complex karyotype by cytogenetic analysis (Table 2) , three of them being hypodiploid (Figure 1 ), two non-diploid and the remaining three pseudodiploid, manifesting complex structural rearrangements (including 1 1q13 rearrangements in one case) (Table 3) .
Ploidy status (Dl vs Cl)
In the subgroup of concordant cases (i.e., non-diploid by both techniques), DI was consistently higher than CI in the series as a whole as well as in a subgroup of oral tumours (both groups P = 0.01). The results of linear regression analysis of the data in this subgroup are presented in Figure 2 (y = 1.1 2x). Of the tumours that were non-diploid according to FCM, 67% (33 out of 49) were diploid according to cytogenetic analysis. However, cytogenetically diploid and non-diploid subgroups did not differ in median DI (1.76 vs 1.81; P = 0.48). All five tumours that were multiploid according to FCM had a normal karyotype.
Spf
The mean Spf among tumours with measurable values (n = 70) was 16.4% (Table 1 ). The mean Spf was higher in the'FCM non-diploid than in the FCM diploid subgroup (18.1% vs 13.1%; P=0.001). The total number of cells in the S-phase region was calculated from the mid-S-phase area, and then divided by the total number of cells. As in diploid tumours a fraction of normal stromal cells may be included in the denominator, the Spf value for diploid tumours may be falsely lower than that for non-diploid tumours. There was no significant difference in mean Spf between cytogenetically non-diploid and diploid/hypodiploid tumours (16.3% vs 16.5%). There was no correlation between tumour karyotype and Spf. 
CV and skewness
The mean CV among tumours with measurable values was 5.3, both for the series as a whole (n = 71) and for the subgroup of tumours diploid according to FCM (n = 23). There was no correlation between CV and any cytogenetic subgroup. In the subgroup diploid according to FCM, 88% (seven out of eight) of tumours with complex karyotype had CV values below the mean value. A skewed GO/GI peak was yielded by five tumours, four of which were diploid according to FCM, but only one of these four tumours had a complex karyotype.
Unsuccessful karyotypes
Of the 31 tumours from which no karyotypes could be obtained, 13 (42%) were diploid according to FCM, with a mean Spf of 13.6 and a mean CV of 5.5. Either the CV values or the ploidy status differed from corresponding results in the study group (P = 0.56 and P = 0.51 respectively). Furthermore, for either diploid or nondiploid tumours, the Spf values differed between the two groups (P = 0.22 and P = 0.10 respectively).
DISCUSSION
A possible explanation of the poor prognostic value of FCM results in cases of SCCHN was yielded by the present study, in which chromosomal changes associated with aggressive tumour growth were found to occur unaccompanied by changes in tumour DNA content. Of 24 tumours diploid according to FCM, eight (33%) had complex karyotypes according to cytogenetic analysis (Table 3) . Three of these eight cases were cytogenetically diploid (CI 1.00-1.02). One of these cases (no. 34) showed 1 1q13 rearrangements. A complex karyotype, in general, and chromosomal abnormalities of 1 1q13, in particular, are correlated to poor prognosis . Another three of the eight Larynx 46, XY, der(5)t(5;10)(q13;q11), 1.00 1.00 i(7)(q1O), der(10)t(7;10)(p11;q11), der( 1 5) del(4)(q28), +i(7)(plO), i(8)(q1O) (14) 34 Larynx 46,XY, del(1)(q42), add(4)(p16), del (9) 1.00 1.00 (q32), t(9;11)(q22;q13), add(10)(q26), add(17)(q25)(7)/46, XY, del(1)(q42), t(1 ;14)(q25;q22), der(6)t(6;16)(p21 ;q22), add(12)(p12), der (16)add (16)(p12) tumours diploid according to FCM were found to be hypodiploid at cytogenetic analysis (Table 1 cases 33, 43 and 69; Figure 1 ). As no internal control can be included in the present FCM preparation technique, hypodiploidy is not applicable, and the first stemline peak appearing to the left in the histogram should be regarded as the diploid (Hiddemann et al, 1984) . However, in other cancer types, e.g. breast cancer, hypodiploidy has been associated with poor prognosis (Ferno et al, 1992a) . To our knowledge, no such relationship has been reported for SCCHN. Finally, two of the eight FCM diploid tumours of complex karyotypes (Table 1 cases  26 and 30) were non-diploid according to cytogenetic analysis. There are several possible reasons why these non-diploid cell populations were not detected by FCM. First, as no bimodality (i.e. two GJG, peaks close together) was seen, nuclei might have been severely maltreated in the preparation procedure for FCM. Second, the cytogenetically detected clone might have been too small to be detected by FCM. Third, it is possible that the tumours were genetically heterogeneous. Intratumour heterogeneity in FCM results has been reported for other tumour types (Ferno et al, 1992b) , a finding in accord with findings in SCCHN in our group (data not shown).
The CV value reflects the width of the G/G1 peak, enabling a more thorough subclassification of the peak. In FCM diploid tumours other than SCCHN, the prognostic value of FCM has been suggested to be enhanced by the use of the CV approach, which enables small near-diploid populations with aggressive biological potential to be identified Gustafson, 1994 (ElNaggar and Pathak, 1992; Breitkreutz et al, 1993) . These findings support the hypothesis that certain non-diploid stemlines are difficult to grow in short-term cell culture, whereas certain diploid clones have a selective growth advantage. These 34 tumours did not differ in DNA content from the 15 tumours non-diploid (Table 1) . A 40-year-dd man with recumrrnt SCCHN of the tongue, clasfed as T3N1MO, with (A)-a-complex hypodpoid karyope: 40-44, XY dlc(1;11)(qlO;pII), der(3;19)(qlO;qlO), ins(4;?)(p14;?), i(6)(pl0), i(6)(q10), ..de4(6q15), 1(8)(qlO), -11, der(13;14)(qlO;qlO), del (16) In the present study, DI values were consistently higher than CI values (Figure 2) , a finding similar to those previously reported by others (Smeets et al, 1987; Remvikos et al, 1988b; , 1993) . There are several possible cytogenetic explanations for this. Chromosomes may be lost during the hypotonic treatment used to obtain good chromosome spread, or if large chromosomes (e.g. chromosomes 1 or 2) are preferentially gained, the DI will be proportionally higher than the CI, which is based on the number of chromosomes and not on their size.
The high rate of unsuccessful cytogenetic analysis in the present investigation (30%) is similar to figures reported for our previous studies (Jin et al, 1993) . From a clinical point of view, this is a major drawback with regard to the applicability of the method to yield prognostic information in SCCHN. Furthermore, if it turns out that some of the cell populations with simple karyotypic changes, e.g. gain or loss of a single chromosome or one or a few balanced structural rearrangements, as the sole anomalies are not representative of the tumour parenchyma, the success rate would be even lower (25 out of 73, 34%).
Furthermore, the present study indicates that DNA ploidy status by FCM provides information of the genetic changes in SCCHN that is too unspecific to be used as a reliable prognostic marker. Possibly, further investigations of Spf could improve this aspect.
